Journal profile · Medicine-Urology

Translational Research in Urology

ISSN 2717-042X · Urology Research Center · Iran, Islamic Republic of

Translational Research in Urology: diamond open access (no APC); no APC; review about 6 weeks (community reports); acceptance rate 30% (journal website); indexed in Scopus.

Impact factor—No published value
CAS zone—Not in the CAS Journal Ranking
CiteScore quartileQ3Urology · rank 86/123
Review timeabout 6 weeksCommunity average
APCNo APCDiamond open access (no APC)
Acceptance30%From the journal's website
Articles per year—No count yet

Scope

Aims, scope and focus

Translational Research in Urology is one of the premier journals in urology translational research. The journal of choice for authors seeking the broadest audience for therapies, diagnostics, emerging technologies, basic sciences, pre-clinical and clinical research, and first-in-man clinical trials. The aim of the journal is to provide a forum for critical evaluation of the novel urology and related science, to showcase important and clinically relevant aspects of the new research, as well as to discuss the impediments that may need to be overcome during the translation to patient care. The journal is dedicated to publish all novel research articles in urology, endourology, and nephrology using the scientific knowledge and experiences of leading and prominent urology experts worldwide. The journal covers all aspects of urology, reproductive medicine, andrology and nehrology from basic sciences to the clinical sciences and its translation and application in daily practice. The journal seeks to present the diseases of the urinary tract-genital system from a new perspective based on biotechnology, gene therapy, cell-based therapy, and individual-based medicine by establishing links between scientific and applied concepts in the field of urology. Translational Research in Urology publishes: Original/ Research Papers Reviews of literature on interesting topics Narrative Reviews Systematic Reviews and Meta-analysis Case Report Case Series Editorial Letter/ Commentary The Journal includes clinical nephrology, renal replacement therapy (dialysis and transplantation), experimental and translational nephrology. Interesting and novel case reports and case series are considered for publication as letters to the editor. Adult and geriatric nephrology are the areas of primary coverage. The urology section welcomes manuscripts in general and pediatric urology as well as all urologic sub-specialties. The main thrust of the publication is significant observations in clinical urology and translational research but will consider reports significant basic science research. Review articles, book reviews, and letters to the editor are welcome.

From the journal's Aims & Scope

Research area (LetPub): Medicine-Urology

Editor-in-chief Seyed MohammadPublisher website

Editorial board by country: none in mainland China; most named Iran 14, Türkiye 2, United States 1, United Kingdom 1, France 1 (23 members with a country) Editorial board ↗Publisher website ·

Rankings & indexing

CAS ranking and database indexing

CAS Journal Ranking

CAS Journal Ranking, upgraded edition (March 2025)Not covered

Not covered by this edition.

CAS Xinrui Journal Ranking (March 2026)Not covered

Not covered by this edition.

CAS Journal Ranking, previous upgraded edition (December 2023)Not covered

Not covered by this edition.

CiteScore quartiles (Scopus, June 2026 release)

SubjectQuartileRankPercentile
UrologyQ386/123—
NephrologyQ363/88—
Reproductive MedicineQ372/99—

Scopus ranks journals by CiteScore within each subject: the 75th percentile and above is Q1, then a quartile every 25 points. A different system from the CAS zones.LetPub

Database indexing

ScopusDOAJLetPub

International journal early-warning lists: not listed in any editionLetPub

Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.

Metrics

Impact metrics and publication volume

Impact

CiteScore 2026-06
1.2LetPub ·
CiteScore (publisher) 2025
1.2Publisher website ·
SJR 2026-06
0.2LetPub ·
SNIP 2026-06
0.23LetPub ·
h-index
0OpenAlex ·
i10-index
0OpenAlex ·
2-year mean citedness
0OpenAlex ·
Share of gold OA articles
0%LetPub ·

Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.

Review & acceptance

Review time and acceptance

Average review time (community reports)
about 6 weeksLetPub ·
Acceptance rate (publisher)
30%Publisher website ·
Submission to publication (journal-reported)
about 6 weeksDOAJ ·
Peer review
Double anonymous peer reviewDOAJ

Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.

Fees & open access

APC and open-access policy

Diamond open access (no APC)DOAJ

Every article is open access and authors pay no article processing charge.

SourceAPCFee waiverLicenseObserved
DOAJNo APCNoCC BY-NC
LetPubNo APCNo—

The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.

Submission

Article types and submission policies (journal website)

What to prepare1 items from the author guidelines
First submission
Free format: the journal's layout is not required
Publisher website · model-extracted, each line checked against the text
Article types accepted3
  1. lettersThe journal publishes original full-length articles, reviews, and letters relevant to all fields of urology translational research.Length not stated
  2. original full-length articlesThe journal publishes original full-length articles, reviews, and letters relevant to all fields of urology translational research.Length not stated
  3. reviewsThe journal publishes original full-length articles, reviews, and letters relevant to all fields of urology translational research.Length not stated
Publisher website
Policy excerpts from the journal's websiteAI use, Publication ethics, Plagiarism
AI use Declaration of generative AI use

Translational Research in Urology requires authors to declare the use of any generative AI or AI-assisted technologies during the preparation of their manuscript. While these tools are recognized for their potential to help researchers work more effectively, they must be used with human oversight and cannot replace critical thinking and expertise. Authors bear full responsibility for their manuscr…

Source ↗Publisher website ·
Publication ethics

Conflict of Interest policy; compliance with international, national, and/or institutional standards on research involving Human Participants and/or Animals and Informed Consent. Model summary

The journal is committed to maintaining the highest level of integrity in the content published. This journal has a Conflict of Interest policy in place and complies with international, national, and/or institutional standards on research involving Human Participants and/or Animals and Informed Consent.

Source ↗Publisher website ·
Plagiarism

May use plagiarism detection software; follows COPE guidelines on plagiarism. Model summary

The journal may use plagiarism detection software to screen the submissions. If plagiarism is identified, the COPE guidelines on plagiarism will be followed.

Source ↗Publisher website ·

Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.

Profile

Publication details and official links

Publisher
Urology Research Center
Country or region
Iran, Islamic Republic of
Language
English
ISSN
2717-042X
Latest issue on the website
Volume 8, Issue 3 (2026)
Official links

FAQ

Frequently asked questions about Translational Research in Urology

How long does peer review take at Translational Research in Urology?

Authors report an average review time of about 6 weeks; the journal's website gives an acceptance rate of 30%. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.

Where are the editorial board members of Translational Research in Urology based?

Of the 23 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Iran (14), Türkiye (2) and United States (1). Counted from the institutions listed on the board page; for reference only.

Which databases index Translational Research in Urology?

According to LetPub and DOAJ records, Translational Research in Urology is indexed in Scopus and DOAJ.

Is Translational Research in Urology open access, and what is the APC?

Translational Research in Urology is a diamond open-access journal (no APC). It charges no article processing charge.

Sources and updates

The facts on this page come from LetPub, Publisher website, OpenAlex, DOAJ; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-28). Last updated: .